The contribution by monoamine oxidase and catechol-O-methyltransferase to the total-body and pulmonary plasma clearance of catecholamines

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 353, Issue 2, 1996, Pages 193-199

  Friedgen, Bernd ^a   Wölfel, Reinhard ^a   Graefe, Karl Heinz ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adrenaline; COMT inhibition; Dopamine; MAO inhibition; Noradrenaline; Pulmonary plasma clearance; Total body plasma clearance

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; ADRENALIN; AMINE OXIDASE (FLAVIN CONTAINING); CATECHOL METHYLTRANSFERASE; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; PARGYLINE; RADIOISOTOPE; TOLCAPONE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HEART OUTPUT; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; LUNG CIRCULATION; MALE; NONHUMAN; PLASMA CLEARANCE; RABBIT; STEADY STATE;

ANIMALS; BENZOPHENONES; CATECHOL O-METHYLTRANSFERASE; CATECHOLAMINES; DOPAMINE; FEMALE; MALE; MONOAMINE OXIDASE; NITROPHENOLS; NOREPINEPHRINE; PARGYLINE; PULMONARY CIRCULATION; RABBITS;

EID: 0030035073     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00168757     Document Type: Article

References (35)

1. Axelrod J (1966) Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. Pharmacol Rev 18:95-113
2. Brown MJ, Davies DS, Dollery CT (1979) Quantitative analysis of noradrenaline clearance. Br J Pharmacol 67:452P-453P
3. Brown MJ, Lhoste FJM, Zamboulis C, Ind PW, Jenner DA, Dollery CT (1982) Estimation of sympathetic activity in essential hypertension. Clin Pharmacol Ther 31:16-22
4. 1 in noradrenergic neurones. Naunyn-Schmiedeberg's Arch Pharmacol 345:319-326
5. 3H-catecholamines in two metabolizing systems. Naunyn-Schmiedeberg's Arch Pharmacol 333:253-261
6. Eisenhofer G (1994) Plasma normetanephrine for examination of extraneuronal uptake and metabolism of noradrenaline in rats. Naunyn-Schmiedeberg's Arch Pharmacol 349:259-269
7. Eisenhofer G, Goldstein DS, Ropchak TG, Nguyen HQ, Keiser HR, Kopin IJ (1988) Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol. J Auton Nerv Syst 24:1-14
8. Esler M (1982) Assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics. Clin Sci (colch) 62:247-254
9. Finberg JPM, Kopin IJ (1986) Chronic clorgyline treatment enhances release of norepinephrine following sympathetic stimulation in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 332: 236-242
10. Friedgen B, Halbrügge T, Graefe K-H (1993a) Plasma clearances and extractions of four catecholamines in the anesthetized rabbit: the role of amine removal by blood cells. J Cardiovasc Pharmacol 21:21-28
11. Friedgen B, Halbrügge T, Graefe K-H (1993b) The part played by catechol-O-methyltransferase in the plasma kinetics of 3,4-dihydroxyphenylglycol and 3,4-dihydroxyphenylalanine in the anesthetized rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 347:155-161
12. 1 and catechol-O-methyltransferase in removal of circulating catecholamines in the rabbit. Am J Physiol 267:E814-E821
13. Fuentes JA, Neff NH (1977) Inhibition by pargyline of cardiovascular amine oxidase activity. Biochem Pharmacol 26:2107-2112
14. Gillis CN, Iwasawa Y (1972) Technique for measurement of norepinephrine and 5-hydroxytryptamine uptake by rabbit lung. J Appl Physiol 33:404-408
15. Gillis CN, Roth JA (1976) Pulmonary disposition of circulating vasoactive hormones. Biochem Pharmacol 25:2547-2553
16. Gillis CN, Roth JA (1977) The fate of biogenic monoamines in perfused rabbit lung. Br J Pharmacol 59:585-590
17. 3H-(-)noradrenaline in the perfused cat and rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 318:71-82
18. Graefe K-H, Bönisch H (1988) The transport of amines across the axonal membranes of noradrenergic and dopaminergic neurones. In: Trendelenburg U, Weiner N (eds) Catecholamines I (Handbook of experimental pharmacology, vol 90/I) Springer, Berlin Heidelberg New York, PP 193-245
19. Graefe K-H, Bönisch H, Trendelenburg U (1971) Time-dependent changes in neuronal net uptake of noradrenaline after pretreatment with pargyline and/or reserpine. Naunyn-Schmiedeberg's Arch Pharmacol 271:1-28
20. Grohmann M (1987) The activity of the neuronal and extraneuronal catecholamine-metabolizing enzymes of the perfused rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 336:139-147
21. Halbrügge T, Gerhardt T, Ludwig J, Heidbreder E, Graefe K-H (1988a) Assay of catecholamines and dihydroxyphenylethyleneglycol in human plasma and its application in orthostasis and mental stress. Life Sci 43:19-26
22. 3H-labelled noradrenaline in the anaesthetized rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 338:361-367
23. Halbrügge T, Lütsch K, Thyen A, Graefe K-H (1991) Role of nitric oxide formation in the regulation of haemodynamics and the release of noradrenaline and adrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 344:720-727
24. Halbrügge T, Friedgen B, Ludwig J, Graefe K-H (1993) Effect of catechol-O-methyltransferase inhibition on the plasma clearance of noradrenaline and the formation of 3,4-dihydroxyphenylglycol in the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 347:162-170
25. Iversen LL (1967) The uptake and storage of noradrenaline in sympathetic nerves. Cambridge University Press, Cambridge
26. Kopin IJ (1972) Metabolic degradation of catecholamines. The relative importance of different pathways under physiological conditions and after administration of drugs. In: Blaschko H., Muscholl E (eds) Catecholamines (Handbook of experimental pharmacology, vol 23) Springer, Berlin Heidelberg New York, pp 270-282
27. Kopin IJ (1985) Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 37:333-364
28. Majewski H, Hedler L, Starke K (1982) The noradrenaline release rate in the anaesthetized rabbit: facilitation by adrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 321:20-27
29. Neff NH, Yang HYT (1974) Another look at the monoamine oxidases and the MAO inhibitor drugs. Life Sci 14:2061-2074
30. Ratge D, Kohse KP, Steegmüller U, Wisser H (1991) Distribution of free and conjugated catecholamines between plasma, platelets and erythrocytes: different effects of intravenous and oral catecholamine administration. J Pharmacol Exp Ther 257:232-257
31. Roth JA, Gillis CN (1975) Multiple forms of amine oxidase in perfused rabbit lung. J Pharmacol Exp Ther 194:537-544
32. Rowland M, Tozer TN (1989) Clinical pharmacokinetics: concepts and applications. Lea and Febiger, Philadelphia, p 152
33. Trendelenburg U (1988) The extraneuronal uptake and metabolism of catecholamines. In: Trendelenburg U, Weiner N (eds) Catecholamines I (Handbook of experimental pharmacology, vol 90/I) Springer, Berlin Heidelberg New York, pp 279-319
34. Trendelenburg U (1990) The interaction of transport mechanisms and intracellular enzymes in metabolizing systems. J Neural Transm [Suppl] 32:3-18
35. Zürcher G, Keller HH, Kettler R, Borgulya J, Bonetti EP, Eigenmann R, Da Prada M (1990) Ro 40-7592, a novel, very potent and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats. Adv Neurol 53:497-503